Clinical factors leading to lamotrigine prescription in bipolar outpatients: Subanalysis of the SIN-DEPRES study

Journal of Affective Disorders

Volumn 143, Issue 1-3, 2012, Pages 102-108

  Grande, I ^a   Balanza Martinez V ^b   Jiménez Arriero, Ma ^c   Iglesias Lorenzo, F G ^d   Franch Valverde, J I ^e   De Arce, R ^f   Zaragoza, S ^g   Cobaleda, S ^h   Vieta, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d Universidad de La Coruña   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g Neuropsychological Research Organization   (Spain)

^h GLAXOSMITHKLINE   (Spain)

Author keywords

Bipolar disorder; Clinical predictors; Community mental health services; Cross sectional studies; Lamotrigine

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ASSESSMENT; COMMUNITY CARE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TRIAZINES;

EID: 84869491708     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.05.035     Document Type: Article

References (53)

1. V. Balanzá-Martínez, G. Selva, A. Martínez- Arán, J. Prickaerts, J. Salazar, A. González-Pinto, E. Vieta, and R. Tabarés-Seisdedos Neurocognition in bipolar disorders - a closer look at comorbidities and medications European Journal of Pharmacology 626 2010 87 96
2. R.J. Baldessarini, J. Undurraga, G.H. Vázquez, L. Tondo, P. Salvatore, K. Ha, H.-M.K. Khalsa, B. Lepri, T.H. Ha, J.S. Chang, M. Tohen, and E. Vieta Predominant recurrence polarity among 928 adult international bipolar I disorder patients Acta Psychiatrica Scandinavica 136 2012 149 154
3. J. Bobes, A. Bulbena, A. Luque, R. Dal-Ré, J. Ballesteros, and N. Ibarra A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale Medicina Clinica (Barcelona) 120 2003 693 700
4. C.M. Bonnín, J. Sánchez-Moreno, A. Martínez- Arán, B. Solé, M. Reinares, A.R. Rosa, J.M. Goikolea, A. Benabarre, J.L. Ayuso-Mateos, M. Ferrer, E. Vieta, and C. Torrent Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability Journal of Affective Disorder 136 2012 650 659
5. C.L. Bowden, J.R. Calabrese, S.L. McElroy, L.J. Rhodes, P.E. Keck Jr, J. Cookson, J. Anderson, C. Bolden-Watson, J. Ascher, E. Monaghan, and J. Zhou The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder Biological Psychiatry 45 1999 953 958
6. C.L. Bowden, J.R. Calabrese, G. Sachs, L.N. Yatham, S.A. Asghar, M. Hompland, P. Montgomery, N. Earl, T.M. Smoot, and J. DeVeaugh-Geiss A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Archives of General Psychiatry 60 2003 392 400
7. J.R. Calabrese, C.L. Bowden, S.L. McElroy, J. Cookson, J. Andersen, P.E. Keck Jr, L. Rhodes, C. Bolden-Watson, J. Zhou, and J.A. Ascher Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder American Journal of Psychiatry 156 1999 1019 1023
8. J.R. Calabrese, C.L. Bowden, G.S. Sachs, J.A. Ascher, E. Monaghan, and G.D. Rudd A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 study group Journal of Clinical Psychiatry 60 1999 79 88
9. J.R. Calabrese, T. Suppes, C.L. Bowden, G.S. Sachs, A.C. Swann, S.L. McElroy, V. Kusumakar, J.A. Ascher, N.L. Earl, P.L. Greene, and E.T. Monaghan A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group Journal of Clinical Psychiatry 61 2000 841 850
10. J.R. Calabrese, C.L. Bowden, G. Sachs, L.N. Yatham, K. Behnke, O.-P. Mehtonen, P. Montgomery, J. Ascher, W. Paska, N. Earl, and J. DeVeaugh-Geiss A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder Journal of Clinical Psychiatry 64 2003 1013 1024
11. J.R. Calabrese, R.F. Huffman, R.L. White, S. Edwards, T.R. Thompson, J.A. Ascher, E.T. Monaghan, and R.A. Leadbetter Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials Bipolar Disorder 10 2008 323 333
12. F. Colom, E. Vieta, C. Daban, I. Pacchiarotti, and J. Sánchez-Moreno Clinical and therapeutic implications of predominant polarity in bipolar disorder Journal of Affective Disorder 93 2006 13 17
13. C. Daban, A. Martínez-Arán, C. Torrent, J. Sánchez-Moreno, J.M. Goikolea, A. Benabarre, M. Comes, F. Colom, and E. Vieta Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results Journal of Clinical Psychopharmacology 26 2006 178 181
14. C. De Dios, E. Ezquiaga, A. Garcia, B. Soler, and E. Vieta Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study Journal of Affective Disorder 125 2010 74 81
15. M.A. Frye, T.A. Ketter, G.S. Leverich, T. Huggins, C. Lantz, K.D. Denicoff, and R.M. Post The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study Journal of Clinical Psychiatry 61 2000 9 15
16. M.A. Frye, K. Ha, S. Kanba, T. Kato, A. Özerdem, G. Vázquez, and E. Vieta International consensus group on depression prevention in bipolar disorder Journal of Clinical Psychiatry 72 2011 1295 1310
17. J.R. Geddes, J.R. Calabrese, and G.M. Goodwin Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials The British Journal of Psychiatry 194 2009 4 9
18. G.M. Goodwin Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology Journal Psychopharmacology (Oxford) 23 2009 346 388
19. G.M. Goodwin, C.L. Bowden, J.R. Calabrese, H. Grunze, S. Kasper, R. White, P. Greene, and R. Leadbetter A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder Journal of Clinical Psychiatry 65 2004 432 441
20. I. Grande, R. de Arce, M.A. Jiménez-Arriero, F.G. Iglesias-Lorenzo, J.I. Franch-Valverde, V. Balanzá-Martínez, S. Zaragoza, S. Cobaleda, and E. Vieta Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES) International Journal of Neuropsychopharmacology 2011 10.1017/S1461145712000405
21. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.-J. Möller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression World Journal of Biological Psychiatry 11 2010 81 109
22. J.M. Haro, C. Reed, A. Gonzalez-Pinto, D. Novick, J. Bertsch, and E. Vieta 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery European Neuropsychopharmacology 21 2011 287 293
23. L.L. Judd, H.S. Akiskal, P.J. Schettler, W. Coryell, J. Endicott, J.D. Maser, D.A. Solomon, A.C. Leon, and M.B. Keller A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder Archives of General Psychiatry 60 2003 261 269
24. L.L. Judd, P.J. Schettler, H.S. Akiskal, W. Coryell, A.C. Leon, J.D. Maser, and D.A. Solomon Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence Archives of General Psychiatry 65 2008 386 394
25. L.V. Kessing, G. Hellmund, and P.K. Andersen An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder Journal of Psychopharmacology 2011 [Epub ahead of print]
26. A. Lobo, L. Chamorro, A. Luque, R. Dal-Ré, X. Badia, and E. Baró Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales Medicina Clinica (Barc) 118 2002 493 499
27. W. Maier, M. Philipp, I. Heuser, S. Schlegel, R. Buller, and H. Wetzel Improving depression severity assessment - I. Reliability, internal validity and sensitivity to change of three observer depression scales Journal of Psychiatric Research 22 1988 3 12
28. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change The British Journal of Psychiatry: The journal of Mental Science 134 1979 382 389
29. A. Murru, F. Colom, A. Nivoli, I. Pacchiarotti, M. Valenti, and E. Vieta When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations European Psychiatry 26 2011 183 186
30. A.M.A. Nivoli, F. Colom, A. Murru, I. Pacchiarotti, P. Castro-Loli, A. González-Pinto, K.N. Fountoulakis, and E. Vieta New treatment guidelines for acute bipolar depression: a systematic review Journal of Affective Disorder 129 2011 14 26
31. A.M.A. Nivoli, I. Pacchiarotti, A.R. Rosa, D. Popovic, A. Murru, M. Valenti, C.M. Bonnin, I. Grande, J. Sanchez-Moreno, E. Vieta, and F. Colom Gender differences in a cohort study of 604 bipolar patients: The role of predominant polarity Journal of Affective Disorder 133 2011 443 449
32. National Collaborative Centre for Mental Health, 2006. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care (Rep. No. NICE Clinical Guideline 38). National Collaborative Centre for Mental Health.
33. I. Pacchiarotti, L. Mazzarini, F. Colom, J. Sanchez-Moreno, P. Girardi, G.D. Kotzalidis, and E. Vieta Treatment-resistant bipolar depression: towards a new definition Acta Psychiatrica Scandinavica 120 2009 429 440
34. R.H. Perlis, M.J. Ostacher, J.K. Patel, L.B. Marangell, H. Zhang, S.R. Wisniewski, T.A. Ketter, D.J. Miklowitz, M.W. Otto, L. Gyulai, N.A. Reilly-Harrington, A.A. Nierenberg, G.S. Sachs, and M.E. Thase Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) American Journal of Psychiatry 163 2006 217 224
35. D. Popovic, M. Reinares, B. Amann, M. Salamero, and E. Vieta Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder Psychopharmacology (Berlin) 213 2011 657 667
36. D. Popovic, M. Reinares, J.M. Goikolea, C.M. Bonnin, A. Gonzalez-Pinto, and E. Vieta Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 22 2012 339 346
37. A.R. Rosa, C.M. Bonnin, L. Mazzarini, B. Amann, F. Kapczinski, and E. Vieta Clinical predictors of interpersonal functioning in patients with bipolar disorder Revista de Psiquiatría y Salud Mental 2 2009 83 88
38. A.R. Rosa, M. Reinares, B. Amann, D. Popovic, C. Franco, M. Comes, C. Torrent, C.M. Bonnín, B. Solé, M. Valentí, M. Salamero, F. Kapczinski, and E. Vieta Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program Bipolar Disorder 13 2011 679 686
39. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP Psychiatry Research 73 1997 159 171
40. T. Suppes, E.B. Dennehy, R.M.A. Hirschfeld, L.L. Altshuler, C.L. Bowden, J.R. Calabrese, M.L. Crismon, T.A. Ketter, G.S. Sachs, and A.C. Swann The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder Journal of Clinical Psychiatry 66 2005 870 886
41. R. Tabarés-Seisdedos, V. Balanzá-Martínez, J. Sánchez-Moreno, A. Martínez-Arán, J. Salazar-Fraile, G. Selva-Vera, C. Rubio, I. Mata, M. Gómez-Beneyto, and E. Vieta Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up Journal of Affective Disorder 109 2008 286 299
42. M. Valentí, I. Pacchiarotti, A.R. Rosa, C.M. Bonnín, D. Popovic, A.M.A. Nivoli, A. Murru, I. Grande, F. Colom, and E. Vieta Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients Bipolar Disorder 13 2011 145 154
43. E. Vieta Long-term treatment of bipolar depression and other issues Journal of Clinical Psychiatry 71 2010 e07
44. E Vieta, and F. Colom Therapeutic options in treatment-resistant depression Annals of Medicine 43 2011 512 530
45. E. Vieta, and T. Suppes Bipolar II disorder: arguments for and against a distinct diagnostic entity Bipolar Disorder 10 2008 163 178
46. E. Vieta, C. Torrent Font, A. Martínez-Arán, F. Colom Victoriano, M. Reinares Gabnepen, A. Benabarre Hernández, M. Comes Forastero, and J.M. Goikolea Alberdi [A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M] Actas Espanolas De Psiquiatria 30 2002 301 304
47. E. Vieta, J. Locklear, O. Günther, M. Ekman, C. Miltenburger, M.L. Chatterton, M. Aström, and B. Paulsson Treatment options for bipolar depression: a systematic review of randomized, controlled trials Journal of Clinical Psychopharmacology 30 2010 579 590
48. E. Vieta, R. de Arce, M.A. Jiménez-Arriero, A. Rodriguez, V. Balanzá, and S. Cobaleda Detection of subclinical depression in bipolar disorder: a cross-sectional, 4-month prospective follow-up study at community mental health services (SIN-DEPRES) Journal of Clinical Psychiatry 71 2010 1465 1474
49. E. Vieta, O. Günther, J. Locklear, M. Ekman, C. Miltenburger, M.L. Chatterton, M. Aström, and B. Paulsson Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials Intenational Journal of Neuropsychopharmacology 14 2011 1029 1049
50. WHO Experts Committee, 1977. La selección de medicamentos esenciales. Rep. no. 615. World Health Organization, Geneve.
51. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'Donovan, G. MacQueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disorder 11 2009 225 255
52. M.L.M. van der Loos, P.G.H. Mulder, E.G.T.M. Hartong, M.B.J. Blom, A.C. Vergouwen, H.J.U.E.M. de Keyzer, P.J.H. Notten, M.L. Luteijn, M.A. Timmermans, E. Vieta, and W.A. Nolen Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial Journal of Clinical Psychiatry 70 2009 223 231
53. M.L.M. van der Loos, P. Mulder, E.G.T.M. Hartong, M.B.J. Blom, A.C. Vergouwen, M.S. van Noorden, M.A. Timmermans, E. Vieta, and W.A. Nolen Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design Bipolar Disorder 13 2011 111 117